The METTL3/miR-196a Axis Predicts Poor Prognosis in Non-small Cell Lung Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.METTL3 upregulation promotes non-small cell lung cancer (NSCLC) progression via the METTL3-miR-196a-GAS7 axis. This pathway influences tumor growth and may serve as a novel diagnostic and therapeutic target for NSCLC.
Area Of Science
- Molecular Oncology
- Cancer Biology
- Epigenetics
Background
- METTL3, an m6A methyltransferase, is implicated in cancer progression, including non-small cell lung cancer (NSCLC).
- Understanding the role of METTL3-mediated upregulation of microRNA-196a (miR-196a) in NSCLC is crucial.
Purpose Of The Study
- To elucidate the function and mechanism of METTL3-driven miR-196a upregulation in NSCLC.
- To investigate the potential of the METTL3-miR-196a-GAS7 axis as a therapeutic target and diagnostic marker for NSCLC.
Main Methods
- Quantitative PCR, Western blot, and immunohistochemistry to assess m6A modification levels.
- Bioinformatic analysis using TCGA, GEPIA, CPTAC, and TIMER databases for gene expression.
- In vitro (cell lines) and in vivo (tumor growth models) experiments to evaluate miR-196a function.
- Interaction analysis between miR-196a and GAS7.
Main Results
- METTL3 and miR-196a were significantly upregulated in NSCLC tissues and correlated with advanced TNM stage, tumor size, metastasis, and poor prognosis.
- Overexpression of miR-196a enhanced NSCLC cell viability and autophagy, while knockdown had opposite effects.
- miR-196a directly interacted with GAS7, and GAS7 expression correlated with immune cell infiltration in the tumor microenvironment.
Conclusions
- The METTL3-miR-196a-GAS7 axis plays a critical role in NSCLC progression.
- This axis represents a promising target for molecular therapy and a potential diagnostic biomarker for NSCLC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...